Atferdsmedisin
@atferdsmedisin
Followers
49
Following
58
Media
5
Statuses
69
Vitenskapen der psykisk og fysisk helse møtes
Oslo, Norway
Joined January 2020
And we’re proud to have Dr @john_munkhaugen as Professor of Behavioural Medicine in our department ✨️
Proud and greatful to share the primary results with this fantastic team (@dan_atar E Prescott AM Kristensen, JE Otterstad) and the Norwegian and Danish cardiac community! Thanks to prof John Cleland for a great discussion. @NEJM @escardio #ESC2025 @VestreViken @atferdsmedisin
0
0
0
Dep. of Behavioural Med. has been evaluated by the Research Council of Norway: "This is an impressive research group that delivers in relation to its aims and objectives...It stands out for taking into account the complexity of biopsychosocial aspects of health and illness." 5/5
0
1
3
Kom og jobb sammen med oss - Spennede stilling som 1. amanuensis / professor innen atferdsmedisin ute nå! Del gjerne! @UniOslo_MED @atferdsmedisin
https://t.co/T5jwj5kQsq
0
3
4
Hjelpe oss å forbedre oppfølgingen etter kreft i ung alder i Norge og i 15 andre europeiske land Svar anonymt her: https://t.co/7uDRRU1y2x
#eQuoLproject #barnekreft #kreft @ungkreft @kreftforeningen @Barnekrfor @atferdsmedisin @UniOslo_MED
0
1
3
Congratulations to our PhD candidate Ingrid Engebretsen on her fantastic presentation at #ESCCongress2024. Non-adherence to PCSk9i and oral LLT is a major challenge in Norway @atferdsmedisin @OsloEconomics @VestreViken @sighalvo @Kristinamalene
2
3
17
Hvorfor skal man følge opp barn og unge som har overlevd kreft?
uio.no
Å være en ung kreftoverlever er ikke det samme som å være helt som før sykdommen. Helsepersonell må være lydhøre, og den som har vært syk trenger å kunne sette ord på sin egen situasjon, ikke minst...
0
1
2
Excellent presentation by our PhD candidate @lauritzen_trine at #ESCPrev2024 ✅ The first study evaluating mevalonate in blood and muscle as potential biomarker of statin intolerance @ntvethe @VestreViken
0
3
12
Availible AND accesseble! Nurse-led motivational interviewing combined with a proactive referral strategy increased access to smoking cessation treatment after hospitalization for atherosclerotic disease https://t.co/Z2udaBSF59
@KarinPleym @atferdsmedisin @VestreViken
academic.oup.com
AbstractAims. To evaluate the effects of a multi-component intervention for smokers hospitalized for atherosclerotic cardiovascular disease (ASCVD) on the
0
3
8
Long-term follow-up of CHD patients <80yrs ☑️ <70% on high-intensity statins, only 25% used ezetimibe ☑️ 22% had treatment gaps >180 days Major potential for improving lipid management after CHD events https://t.co/OJU8JJctof
@VestreViken @atferdsmedisin @OsloEconomics @sighalvo
atherosclerosis-journal.com
Proper prescription and high adherence to intensive lipid lowering drugs (LLD) in patients with coronary heart disease (CHD) are crucial and strongly recommended. The aim of this study is to invest...
0
2
5
Our two-week elective on "Cancer Communication" for medical students @UniOslo_MED. Yesterday, we reflected on death @munchmuseet. Today we visited The Cancer Society. Tomorrow, @kreftregisteret and The Radium Hospital. We are #Making_Sense_of_Cancer @Ingridsross @CathrineEide
1
1
14
In an exploratory case-control study atovastatin metabolites appear promising as biomarkers for the identification of clinical statin intolerance in patients with self-perceived statin side effects. https://t.co/vApOQg65tS
@ATHjournal
@ntvethe
0
3
12
We have validated a novel method that discriminates reduced adherence from adherence to atorvastatin therapy with high diagnostic accuracy. The tool may contribute to improve lipid management. https://t.co/oRkoWdbtxP
@Jonaspivoriunas @ntvethe @FagerlandWang #EHJCVP
academic.oup.com
AbstractAims. Objective methods to determine statin adherence are requested to improve lipid management. We have recently established a method to detect re
0
1
5
Spesielt gratulerer til @HanneCLie1 fra Avd. for atferdsmedisin!
Salg av rosa sløyfer, medlemskontigent, testament og gaver ga 220 mill til 28 forskere fra @Kreftforeningen🎗️Gratulerer! 👏 Spesielt stolte av @mkuijjer @Sahu_B @AMathelier @HanneCLie1 @AnpBellanger @ragnhildes1 @kschink @MontaldoNicola @harald_stenmark
0
2
6
Mer åpenhet om døden og mindre hype av fantastiske "kurer" så vil mange få en bedre slutt på livet. @DagensMedisin @Kreftforeningen @kreftregisteret @brystkr @Prostatakreft @norilco_norge @aldringoghelse #Kreft
#Løsningen_på_kreftgåten
dagensmedisin.no
– Vi er nødt til å formidle håp uten at det bare er knyttet til oppstart av en ny behandlingslinje, sier overlege og forsker Kristina Lindemann.
0
3
16
Interesting poster presentations at the #SUSTAINIT strategy seminar! @jarlebreivik and @CarolinaRau3 are presenting their fantastic TEAMS project @eivinden @UniOslo_GH
0
3
11
'How Edvard Munch helps unlock ‘the secret’ of death' Read our latest blog post here 👇 https://t.co/nf6copS8Uc
@UniOslo_MED | @munchmuseet | @hospicebardo
0
3
6
How Edvard Munch helps unlock 'the secret' of death - a new way to help medical students relate to death and dying @atferdsmedisin @UniOslo_MED @jarlebreivik @CarolinaRau3 @munchmuseet
0
1
6
Lyst å delta i en kort spørreundersøkelse (på norsk) om kroppslukt? https://t.co/vWFVG9IxgE Du kan vinne et gavekort til en verdi av 100 kroner. Tusen takk! @smellodiEU Steve Shook, CC BY 2.0 < https://t.co/ncEwNVuyfx>, via Wikimedia Commons
0
1
7